Eagle Rock Investment Company’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
Eagle Rock Investment Company's BMY Position: Q2 2026 in Review
Eagle Rock Investment Company held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 20,874 shares worth $1.2M. The position accounts for 0.15% of the portfolio, ranked #88.
Eagle Rock Investment Company first reported a position in BMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $10M in Q4 2021. 1,086 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Eagle Rock Investment Company held 20,874 shares of Bristol-Myers Squibb worth $1.2M as of Q2 2026.
- Eagle Rock Investment Company left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up 0.15% of Eagle Rock Investment Company's portfolio in Q2 2026, its #88 holding.
- Eagle Rock Investment Company first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 19 quarters since.
- Eagle Rock Investment Company's Bristol-Myers Squibb position peaked at $10M in Q4 2021.
- 1,086 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Eagle Rock Investment Company's 13F filing for Q2 2026, filed 9 Jul 2026.